Lupin gets US FDA approval for dimethyl fumarate delayed release capsules
According to IQVIA MAT June 2020 data, dimethyl fumarate delayed-release capsules had an annual sales of approximately USD 3788…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dimethyl Fumarate Delayed-Release Capsules
Mylan announces launch of generic version of Biogen’s Tecfidera
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)
Glenmark receives ANDA approval for Dimethyl Fumarate Delayed-Release capsules
The drug is indicated to treat relapsing forms of multiple sclerosis Glenmark Pharmaceuticals has been granted tentative…